Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
StockStory.org on MSN
Thermo Fisher (NYSE:TMO) posts better-than-expected sales in Q4 CY2025
Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2025 results , with sales up 7.2% year on year to $12.22 billion ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2025.
Thermo Fisher Scientific has received a total of 8 ratings from analysts, with the consensus rating as Buy. With an average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results